We are live on
!
Find out more
CLYM
Climb Bio
CLYM
CLYM
80 hedge funds and large institutions have $221M invested in Climb Bio in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
170% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 10
40% more capital invested
Capital invested by funds: $157M → $221M (+$63.7M)
23% more funds holding
Funds holding: 65 → 80 (+15)
21.8% more ownership
Funds ownership: 45.79% → 67.6% (+22%)
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
25
Reduced
23
Closed
10
Calls
$669K
Puts
–
Net Calls
+$669K
Net Calls Change
+$669K
Top Buyers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
+$8.82M |
| 2 |
Millennium Management
New York
|
+$5.65M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.95M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.71M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.05M |
Top Sellers
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$4.82M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.79M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
-$3.46M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.96M |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$2.64M |
